CLINICAL STUDY: HEART FAILURE
Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems
Ralf Sodian, MD*,*,
Matthias Loebe, MD, PhD*  ,
Christoph Schmitt, MD*,
Evgenij V. Potapov, MD*,
Henryk Siniawski, MD*,
Johannes Müller, MD*,
Harald Hausmann, MD*,
Heinz R. Zurbruegg, MD*,
Yuguo Weng, MD, PhD* and
Roland Hetzer, MD, PhD*
* Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TexasUSA
Manuscript received April 4, 2001;
revised manuscript received August 21, 2001,
accepted August 31, 2001.
* Reprint requests and correspondence: Dr. Ralf Sodian, Department of Thoracic and Cardiovascular Surgery, German Heart Institute Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
sodian{at}dhzb.de
OBJECTIVES
We sought to investigate the relationship between the plasma concentration of brain natriuretic peptide (BNP), echocardiographic findings and the clinical outcome of patients supported with ventricular assist devices (VADs) to determine the role of BNP as a predictor for cardiac recovery.
BACKGROUND
Ventricular unloading in patients with end-stage heart failure supported by VADs may lead to myocardial recovery. The BNP is produced in the myocardium in response to chronic volume overload, but the effects on it of ventricular unloading by VADs are largely unknown.
METHODS
Twenty-one patients diagnosed with nonischemic cardiomyopathy and supported by VADs were evaluated for echocardiographic data and blood chemistry including BNP. They were divided into patients who died while on mechanical support (group I; n = 9), patients who were transplanted (group II; n = 8) and patients who were successfully weaned off the system and did not require transplantation (group III; n = 4).
RESULTS
Brain natriuretic peptide plasma concentrations decreased significantly after initiation of mechanical circulatory support (p = 0.017). Furthermore, the changes in BNP plasma concentrations showed a faster decrease to normal levels within the first week after implantation of the VAD in patients who were weaned off the system (group III) compared to patients in group I and group II.
CONCLUSIONS
This study shows that ventricular unloading with VADs decreases BNP plasma concentrations in patients who suffer from end-stage heart failure. Furthermore, we hypothesize that an early decrease of BNP plasma concentration may be indicative of recovery of ventricular function during mechanical circulatory support.
|
Abbreviations and Acronyms
| | ANP | = atrial natriuretic peptide | | BNP | = brain natriuretic peptide | | BVAD | = biventricular assist device | | LVAD | = left ventricular assist device | | LVEF | = left ventricular ejection fraction | | NYHA | = New York Heart Association | | TEE | = transesophageal echocardiography | | VAD | = ventricular assist device |
|
This article has been cited by other articles:
|
|
|
|
 
K. Toischer, H. Kogler, G. Tenderich, C. Grebe, T. Seidler, P. N. Van, K. Jung, R. Knoll, R. Korfer, and G. Hasenfuss
Elevated Afterload, Neuroendocrine Stimulation, and Human Heart Failure Increase BNP Levels and Inhibit Preload-Dependent SERCA Upregulation
Circ Heart Fail,
November 1, 2008;
1(4):
265 - 271.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Chikovani, J.-H. Hsu, R. Keller, T. R. Karl, A. Azakie, I. Adatia, P. Oishi, and J. R. Fineman
B-type natriuretic peptide levels predict outcomes for children on extracorporeal life support after cardiac surgery.
J. Thorac. Cardiovasc. Surg.,
November 1, 2007;
134(5):
1179 - 1187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-C. Huang, E.-T. Wu, W.-J. Ko, L.-P. Lai, J. Hsu, C.-I. Chang, I.-S. Chiu, S.-S. Wang, M.-H. Wu, F.-Y. Lin, et al.
Clinical Implication of Blood Levels of B-Type Natriuretic Peptide in Pediatric Patients on Mechanical Circulatory Support
Ann. Thorac. Surg.,
June 1, 2006;
81(6):
2267 - 2272.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kubanek, I. Malek, J. Kautzner, M. Hegarova, M. Wiendl, P. Lupinek, L. Karasova, and V. Lanska
The value of B-type natriuretic peptide and big endothelin-1 for detection of severe pulmonary hypertension in heart transplant candidates
Eur J Heart Fail,
December 1, 2005;
7(7):
1149 - 1155.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Matsumiya, O. Monta, N. Fukushima, Y. Sawa, T. Funatsu, K. Toda, and H. Matsuda
Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?
J. Thorac. Cardiovasc. Surg.,
September 1, 2005;
130(3):
699 - 704.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Steg, L. Joubin, J. McCord, W. T. Abraham, J. E. Hollander, T. Omland, F. Mentre, P. A. McCullough, A. S. Maisel, and for the Breathing Not Properly Multinational Study
B-Type Natriuretic Peptide and Echocardiographic Determination of Ejection Fraction in the Diagnosis of Congestive Heart Failure in Patients With Acute Dyspnea
Chest,
July 1, 2005;
128(1):
21 - 29.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. V. Potapov, F. Hennig, F. D. Wagner, H.-D. Volk, R. Sodian, H. Hausmann, H. B. Lehmkuhl, and R. Hetzer
Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure
Eur. J. Cardiothorac. Surg.,
May 1, 2005;
27(5):
899 - 905.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Lisy, M. M. Redfield, J. A. Schirger, and J. C. Burnett Jr.
Atrial BNP endocrine function during chronic unloading of the normal canine heart
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 2005;
288(1):
R158 - R162.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kemperman, M. van den Berg, H. Kirkels, and N. de Jonge
B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP in Patients with End-Stage Heart Failure Supported by a Left Ventricular Assist Device
Clin. Chem.,
September 1, 2004;
50(9):
1670 - 1672.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Jortani, S. D. Prabhu, and R. Valdes Jr
Strategies for Developing Biomarkers of Heart Failure
Clin. Chem.,
February 1, 2004;
50(2):
265 - 278.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Prahash and T. Lynch
B-Type Natriuretic Peptide: A Diagnostic, Prognostic, and Therapeutic Tool in Heart Failure
Am. J. Crit. Care.,
January 1, 2004;
13(1):
46 - 53.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Maisel, J. McCord, R. M. Nowak, J. E. Hollander, A. H. B. Wu, P. Duc, T. Omland, A. B. Storrow, P. Krishnaswamy, W. T. Abraham, et al.
Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: Results from the Breathing Not Properly Multinational Study
J. Am. Coll. Cardiol.,
June 4, 2003;
41(11):
2010 - 2017.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. C. Blaxall, B. M. Tschannen-Moran, C. A. Milano, and W. J. Koch
Differential gene expression and genomic patient stratification following left ventricular assist device support
J. Am. Coll. Cardiol.,
April 2, 2003;
41(7):
1096 - 1106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Maisel, P. Krishnaswamy, R. M. Nowak, J. McCord, J. E. Hollander, P. Duc, T. Omland, A. B. Storrow, W. T. Abraham, A. H.B. Wu, et al.
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
N. Engl. J. Med.,
July 18, 2002;
347(3):
161 - 167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Maisel
B-Type Natriuretic Peptide Levels: Diagnostic and Prognostic in Congestive Heart Failure: What's Next?
Circulation,
May 21, 2002;
105(20):
2328 - 2331.
[Full Text]
[PDF]
|
|
|
|
